tm logo
PROTAGONIST THERAPEUTICS
Live/Pending
FIRST EXTENSION - GRANTED

granted

on 12 Mar 2024

Last Applicant/ Owned by

7707 GATEWAY BLVD, SUITE 140

Newark

CA

94560

Serial Number

97822178 filed on 03rd Mar 2023

Registration Number

N/A

Correspondent Address

Frances M. Jagla

CHRISTENSEN O'CONNOR JOHNSON KINDNESS

1201 THIRD AVENUE, SUITE 3600

SEATTLE,WA 98101

Filing Basis

1. intent to use

2. intent to use current

3. filed as use application

4. use application currently

Disclaimer

"THERAPEUTICS"

PROTAGONIST THERAPEUTICS

Medical research and medical research information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders; Scientific research, pharmaceutical research, medical research; technical consultation services in the field of research and product development for the treatment of immune mediated diseases, inflammatory diseases, oncological disorders and rare diseases; scientiRead More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Providing healthcare information to healthcare professionals and patients relating to disease states and treatment options; Medical information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders

Class [042]
Computer & Software Services & Scientific Services


Medical research and medical research information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders; Scientific research, pharmaceutical research, medical research; technical consultation services in the field of research and product development for the treatment of immune mediated diseases, inflammatory diseases, oncological disorders and rare diseases; scientific consultation services in the fields of immune mediated diseases, inflammatory diseases, oncological disorders and rare diseases; product development services for others in the fields of immune mediated diseases, inflammatory diseases, oncological disorders and rare diseases; research and development of new products pertaining to the treatment of immune mediated diseases, inflammatory diseases, oncological and rare diseases


First Use Date in General

22nd Aug 2006

First Use Date in Commerce

22nd Aug 2006

Class [005]
Pharmaceutical Products


Pharmaceuticals for use in the treatment of cancer and blood diseases and disorders; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for the treatment of metabolic disorders

Mark Details


Serial Number

No 97822178

Mark Type

No Service Mark

Attorney Docket Number

No 4230-T4US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
13th Mar 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12th Mar 2024SOU TEAS EXTENSION RECEIVED
12th Mar 2024SOU EXTENSION 1 FILED
12th Mar 2024SOU EXTENSION 1 GRANTED
24th Oct 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
29th Aug 2023PUBLISHED FOR OPPOSITION
29th Aug 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09th Aug 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
20th Jul 2023APPROVED FOR PUB - PRINCIPAL REGISTER
18th Jul 2023TEAS/EMAIL CORRESPONDENCE ENTERED